Study of NCOA3 yields novel findings of melanoma progression
Study links genes with function across the human brain
25 March 2021Gen X, millennials in worse health than prior generations at same age
25 March 2021Study of NCOA3 yields novel findings of melanoma progression
For the first time, activation of nuclear receptor coactivator 3 (NCOA3) has been shown to promote the development of melanoma through regulation of ultraviolet radiation (UVR) sensitivity, cell cycle progression and circumvention of the DNA damage response. Results of a pre-clinical study led by Mohammed Kashani-Sabet, M.D., Medical Director of the Cancer Center at Sutter’s California Pacific Medical Center (CPMC) in San Francisco, CA were published online today in Cancer Research, a journal of the American Association for Cancer Research.
